All Stories

  1. Somatosensory Evoked Potentials in Spinocerebellar Ataxia Type 3 and Type 10
  2. Ozzy Osbourne and Parkinson's disease: from darkness to awareness
  3. Revisiting Nomenclature in Movement Disorders: The Boundaries Between Pragmatism, Academicism, and Practical Applicability
  4. Targeting Cognitive Dysfunction in Spinocerebellar Ataxia Type 2 Through Digital Cognitive Training
  5. The cerebellum in dystonia: key player or background support?
  6. The cognitive cerebellum: a hub for motor, emotional, and executive control
  7. The cerebellum beyond motor control: cognitive dysfunction in spinocerebellar ataxias
  8. Gilles de La Tourette syndrome: the contribution of Guinon
  9. The cerebellar involvement in essential tremor: the connecting roads
  10. Cognitive Changes in Pre‐ataxic Spinocerebellar Ataxias: A Scoping Review
  11. Alix Joffroy (1844–1908)
  12. Spinocerebellar Ataxia Type 10 (SCA 10) in Brazil
  13. How great was the influence of his origins and descendants on Charcot's behaviors?
  14. Arquivos de Neuro-Psiquiatria: 82 years old, a new phase begins now
  15. Charcot's Russian pupils
  16. Fulgence Raymond: from rural life and veterinary medicine to Charcot's successor at La Salpêtrière Hospital
  17. A hiatus in the rivalry between Pierre Marie and Jules Dejerine: a collaborative study on sensory disorders by Andre Pierre Marie and Gustave Roussy
  18. The prominent role of Charcot and the French neurological tradition in Latin America
  19. François Rabelais and his dystonic giants
  20. The Huntington's Disease Gene Discovery
  21. Static posturography analysis for postural instability in patients with Parkinson’s disease
  22. Imbalance and gait impairment in Parkinson’s disease: discussing postural instability and ataxia
  23. Jean-Martin Charcot: the polymath
  24. Autosomal Recessive Cerebellar Ataxias: New Acronyms, Old Eponyms, and the Butterfly Life Cycle
  25. Chronic Pain And Levodopa Therapy in Parkinson’s Disease Patients
  26. The expulsion of Augusta Dejerine-Klumpke from the Salpêtrière Hospital: Pierre Marie's revenge
  27. The importance of the Brazilian Society of Neurological Investigation (SBIN)
  28. Thomas Willis' legacy on the 400th anniversary of his birth
  29. Inherited metabolic diseases mimicking hereditary spastic paraplegia (HSP): a chance for treatment
  30. Ramsay Hunt syndrome: New impressions in the era of molecular genetics
  31. “I’m gonna lose my strength, I’m gonna seize and die, And all that Jazz”! Neurological diseases in jazz legends
  32. Functionality and disease severity in spinocerebellar ataxias
  33. Evaluation of Brain SPECT with 99mTc‐TRODAT‐1 in the Differential Diagnosis of Parkinsonism
  34. Reply to: “Cognitive Impairments in Spinocerebellar Ataxia Type 10 and Their Relation to Cortical Thickness”
  35. Constantin von Economo´s 90th death anniversary
  36. Would Charcot’s “hystero-epilepsy” be a hypofunction of the NMDA receptors?
  37. Treatment of occipital neuralgia using onabotulinum toxin A
  38. Would Francisco Soca have been the first to relate toe phenomenon as pyramidal disorders?
  39. Spinocerebellar ataxia type 21 (TMEM240) with tremor and dystonia
  40. Patients with Cervical Dystonia Demonstrated Decreased Cognitive Abilities and Visual Planning Compared to Controls
  41. Freezing of gait (FOG) in Parkinson’s disease patients—the contribution of Garcin and Melaragno
  42. Reply
  43. It Is Time to Define Huntington's Disease Onset more Clearly
  44. Autosomal‐Recessive Cerebellar Ataxias and Movement Disorders With Elevated Alpha‐Fetoprotein
  45. Charcot: Buddhist Leanings?
  46. Nobel and Charcot in Paris: A Brazilian Connection?
  47. The Art of Charcot: An Outstanding Caricaturist
  48. Balance and physical functioning in Spinocerebellar ataxias 3 and 10
  49. Is Ataxia an Underestimated Symptom of Huntington's Disease?
  50. Follow-Up of Advanced Parkinson’s Disease Patients after Clinical or Surgical Emergencies: A Practical Approach
  51. The Role of the Cerebellum in Huntington’s Disease: a Systematic Review
  52. Upward Gaze Palsy: a Valuable Sign to Distinguish Spinocerebellar Ataxias
  53. Volumetric MRI Changes in Spinocerebellar Ataxia (SCA3 and SCA10) Patients
  54. Tribute to Professor Andrew J. Lees
  55. Comment on: “Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease‐affected families.”
  56. Neurology, psychiatry and the chess game: a narrative review
  57. Reply to Comment on: The Geographic Diversity of Spinocerebellar Ataxias (SCAs) in the Americas
  58. Assessment of ventilatory function in patients with spinocerebellar ataxia type 2
  59. Blepharospasm and periorbital edema after imatinib mesylate: improvement with botulinum toxin
  60. Charcot and His Passion for Dogs: A Historical Note
  61. Is fatigue an important finding in patients with spinocerebellar ataxia type 10 (SCA10)?
  62. The Duels of Pierre Marie and Jules Dejerine
  63. Reply to Comment on: The geographic diversity of spinocerebellar ataxias (SCAs) in the Americas: A systematic review
  64. Overcoming bashfulness: how cocaine aided Freud to summon the courage to meet Charcot
  65. Spinocerebellar ataxias in Southern Brazil: Genotypic and phenotypic evaluation of 213 families
  66. Nonmotor symptoms in spinocerebellar ataxias (SCAs)
  67. The Geographic Diversity of Spinocerebellar Ataxias (SCAs) in the Americas: A Systematic Review
  68. Charcot's paradox
  69. Sporadic adult-onset spinocerebellar ataxias
  70. Hyposkillia and spanophilia in the movement disorders rounds
  71. Reply to: Early distinction of Parkinson variant multiple system atrophy from Parkinson's disease
  72. The Legacy of Charles David Marsden: A Role Model in the Field of Movement Disorders
  73. The Melted Statue of Charcot: The Nazi Occupation of Paris During World War II
  74. The Effectiveness of Reality Orientation Therapy in the Treatment of Parkinson Disease Dementia
  75. Association between olfactory loss and cognitive deficits in Parkinson's disease
  76. Abnormal Findings in Polysomnographic Recordings of Patients with Spinocerebellar Ataxia Type 2 (SCA2)
  77. Édouard Brissaud: distinguished neurologist and Charcot’s pupil
  78. Yawning in neurology: a review
  79. “ Flâneur neurologique in paris” – A guide to pinpointing the houses of famous neurologists in the late XIX century
  80. Antisense Oligonucleotide Therapy for Spinocerebellar Ataxias: Good News for Terrible Diseases
  81. Sleep disorders in spinocerebellar ataxia type 10
  82. When multiple sclerosis and X-linked adrenoleukodystrophy are tangled
  83. Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease?
  84. Broken dynasty: how Jean Batiste Charcot relinquished his father’s neurological empire to conquer the seven seas
  85. More than ataxia – Movement disorders in ataxia-telangiectasia
  86. Searching for neurological diseases in the Julio-Claudian dynasty of the Roman Empire
  87. Different Cerebellar Ataxia Phenotypes Associated with Mutations of the PNPLA6 Gene in Brazilian Patients with Recessive Ataxias
  88. Apathy and depression in Parkinson Disease Dementia
  89. Attention deficit hyperactivity disorder and drug addiction rehabilitation patients
  90. Neurophysiological and neuroimaging changes (crossed cerebrocerebellar atrophy) after prolonged non-convulsive status epilepticus
  91. Classification and Characteristics of Pain Associated with Parkinson’s Disease
  92. Tourette's syndrome in famous musicians
  93. Cerad battery can be used for the diagnosis of dementia in Parkinson's disease?
  94. Pain assessment in wearing off period of levodopa treatment for Parkinson’s disease
  95. Dysphagia in Dystonia
  96. Dysphagia in Parkinson’s Disease
  97. Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment
  98. The genetics of the dystonias – a review based on the new classification of the dystonias
  99. The Effectiveness of Reality Orientation in the Treatment of Alzheimer’s Disease
  100. Abnormal Cerebrovascular Reactivity in Patients with Parkinson’s Disease
  101. Genetic evaluation for TOR1-A (DYT1) in Brazilian patients with dystonia
  102. Evolution of the concept of dystonia
  103. Cervical dystonia: about familial and sporadic cases in 88 patients
  104. Cervical dystonia: clinical and therapeutic features in 85 patients
  105. Movement disorders secondary to long-term treatment with cyclosporine A
  106. Frequency of obsessive and compulsive symptoms in patients with blepharospasm and hemifacial spasm
  107. Frequency of obsessive and compulsive symptoms in patients with blepharospasm and hemifacial spasm
  108. Uso do propranolol de ação prolongada em 40 pacientes com tremor essencial e virgens de tratamento: um ensaio clínico não controlado
  109. Myotonia congenita and myoadenylate deaminase deficiency: case report
  110. Hemimasticatory spasm treated with botulinum toxin: case report
  111. Machado-Joseph disease versus hereditary spastic paraplegia: case report
  112. Hereditary spastic paraplegia associated with thin corpus callosum
  113. Reversible posterior leucoencephalopathy syndrome associated with bone marrow transplantation
  114. Acidente vascular cerebral em pacientes jovens: análise de 164 casos
  115. Alpha-Synucleinopathies
  116. Neurosurgical Treatments of Neurodegenerative Disorders
  117. Stroke